Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,531 | -1,140 | -6,477 | -5,220 | -2,673 |
| Depreciation Amortization | 110 | 55 | 528 | 158 | 105 |
| Accounts payable and accrued liabilities | 423 | 266 | -779 | -556 | -241 |
| Other Working Capital | 453 | 343 | -691 | -666 | -198 |
| Other Operating Activity | -357 | -200 | 2,912 | 2,617 | 559 |
| Operating Cash Flow | $-1,903 | $-676 | $-4,508 | $-3,667 | $-2,448 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -23 | -153 | -131 | -107 |
| Purchase Sale Intangibles | -24 | -6 | -41 | -40 | -18 |
| Other Investing Activity | -24 | -6 | -41 | -40 | -26 |
| Investing Cash Flow | $-47 | $-29 | $-194 | $-171 | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 50 | N/A |
| Other Financing Activity | 4,825 | 2,361 | 6,970 | 4,595 | 4,620 |
| Financing Cash Flow | $4,825 | $2,361 | $6,970 | $4,645 | $4,620 |
| Beginning Cash Position | 9,224 | 9,224 | 6,956 | 6,956 | 6,956 |
| End Cash Position | 12,099 | 10,879 | 9,224 | 7,763 | 8,995 |
| Net Cash Flow | $2,875 | $1,655 | $2,268 | $808 | $2,039 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,903 | -676 | -4,508 | -3,667 | -2,448 |
| Capital Expenditure | -23 | -23 | -153 | -131 | -107 |
| Free Cash Flow | -1,926 | -700 | -4,661 | -3,798 | -2,555 |